294 related articles for article (PubMed ID: 24227634)
1. Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.
Jans J; Vissers M; Heldens JG; de Jonge MI; Levy O; Ferwerda G
Rev Med Virol; 2014 Jan; 24(1):55-70. PubMed ID: 24227634
[TBL] [Abstract][Full Text] [Related]
2.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
3. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
4. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.
Collins PL; Melero JA
Virus Res; 2011 Dec; 162(1-2):80-99. PubMed ID: 21963675
[TBL] [Abstract][Full Text] [Related]
5. Consequences of immature and senescent immune responses for infection with respiratory syncytial virus.
Malloy AM; Falsey AR; Ruckwardt TJ
Curr Top Microbiol Immunol; 2013; 372():211-31. PubMed ID: 24362692
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
[TBL] [Abstract][Full Text] [Related]
7. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.
Taleb SA; Al Thani AA; Al Ansari K; Yassine HM
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1817-1827. PubMed ID: 29876771
[TBL] [Abstract][Full Text] [Related]
8. The adaptive immune response to respiratory syncytial virus.
Varga SM; Braciale TJ
Curr Top Microbiol Immunol; 2013; 372():155-71. PubMed ID: 24362689
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
Munoz FM
Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
[TBL] [Abstract][Full Text] [Related]
11. Development of innate and adaptive immunity to RSV in young children.
Parsons EL; Kim JS; Malloy AMW
Cell Immunol; 2024; 399-400():104824. PubMed ID: 38615612
[TBL] [Abstract][Full Text] [Related]
12. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
[TBL] [Abstract][Full Text] [Related]
13. Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels.
Vissers M; Ahout IM; de Jonge MI; Ferwerda G
Clin Vaccine Immunol; 2015 Dec; 23(3):243-5. PubMed ID: 26656116
[TBL] [Abstract][Full Text] [Related]
14. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
15. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
Farrag MA; Almajhdi FN
Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
[TBL] [Abstract][Full Text] [Related]
16. Human Respiratory Syncytial Virus: An Introduction.
Jorquera PA; Anderson L; Tripp RA
Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immunity to RSV in infants, children and adults.
Green CA; Sande CJ; de Lara C; Thompson AJ; Silva-Reyes L; Napolitano F; Pierantoni A; Capone S; Vitelli A; Klenerman P; Pollard AJ
Vaccine; 2018 Oct; 36(41):6183-6190. PubMed ID: 30177258
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort.
Yildiz M; Kara M; Sutcu M; Mese S; Demircili ME; Sivrikoz TS; Torun SH; Agacfidan A; Coban A; Unuvar E; Somer A
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1279-1286. PubMed ID: 32060753
[TBL] [Abstract][Full Text] [Related]
19. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
20. The immune response to respiratory syncytial virus infection: friend or foe?
Welliver RC
Clin Rev Allergy Immunol; 2008 Apr; 34(2):163-73. PubMed ID: 17985249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
